Literature DB >> 7696120

Cardiac tamponade as a terminal event in the hemolytic uremic syndrome in childhood.

P E Birk1, S Chakrabarti, A G Lacson, M R Ogborn.   

Abstract

The case of a 6-year-old Inuit female with the epidemic form of hemolytic uremic syndrome (HUS) with myocardial involvement and probable cardiac tamponade is presented. This case illustrates the multisystemic nature of the syndrome, and to our knowledge, cardiac tamponade as a probable terminal event in HUS has not been reported previously.

Entities:  

Mesh：

Year:  1994        PMID： 7696120     DOI： 10.1007/bf00869112

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


  2 in total

1.  Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects.

Authors:  D V Milford; C M Taylor; B Guttridge; S M Hall; B Rowe; H Kleanthous
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

2.  The importance of nonrenal involvement in hemolytic-uremic syndrome.

Authors:  K Upadhyaya; K Barwick; M Fishaut; M Kashgarian; N J Siegel
Journal:  Pediatrics       Date:  1980-01       Impact factor: 7.124
  2 in total
  5 in total

Review 1.  Direct cardiac involvement in childhood hemolytic-uremic syndrome: case report and review of the literature.

Authors:  Davide Rigamonti; Giacomo D Simonetti
Journal:  Eur J Pediatr       Date:  2016-09-23       Impact factor: 3.183

2.  Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).

Authors:  Myda Khalid; Sharon Andreoli
Journal:  Pediatr Nephrol       Date:  2018-11-01       Impact factor: 3.714

3.  Cardiac Manifestation among Children with Hemolytic Uremic Syndrome.

Authors:  Emily Sanders; Clare C Brown; Richard T Blaszak; Brendan Crawford; Parthak Prodhan
Journal:  J Pediatr       Date:  2021-04-02       Impact factor: 6.314

Review 4.  Extra-renal manifestations of complement-mediated thrombotic microangiopathies.

Authors:  Johannes Hofer; Alejandra Rosales; Caroline Fischer; Thomas Giner
Journal:  Front Pediatr       Date:  2014-09-08       Impact factor: 3.418

5.  Renal and pulmonary thrombotic microangiopathy triggered by proteasome-inhibitor therapy in patient with smoldering myeloma: A renal biopsy and autopsy case report.

Authors:  Clarissa A Cassol; Michael P A Williams; Tiffany N Caza; Sophia Rodriguez
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.